ulrich medical USA® Delivers Seventh Consecutive Year of Profitable Double-Digit Growth
Reports 15%, 5-Year Revenue CAGR Performance in U.S. Spine Market
ST. LOUIS, MO (March 7, 2018) – ulrich medical USA Inc., a medical device company focused on developing and commercializing musculoskeletal implant technologies in the United States, today reported 2017 financial results with 10% annual revenue growth for the year ending December 31, 2017 and a 15%, 5-year compound annual growth rate (CAGR) in their U.S. spine market business.
